Pricing Log in Create free account

Lunai Bioworks Inc. (LNAI) vs Nuvilex Inc. (PMCB)

Lunai Bioworks Inc. and Nuvilex Inc. are both Biotechnology companies. Lunai Bioworks Inc. and Nuvilex Inc. are of similar size ($4.2M and $3.8M). Nuvilex Inc. has the higher net margin (0.00% vs −3,761.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Lunai Bioworks Inc. leads on 6 and Nuvilex Inc. on 5.

Valuation

Metric LNAI PMCB Biotechnology median
P/E n/m n/m 8.50
P/S 24.13 n/m 9.71
P/B n/m 0.13 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 3.82 0.64
EV/Sales 18.71 n/m 9.21
Earnings yield (150.78%) (679.41%) (33.15%)
Free cash flow yield (232.47%) (290.03%) (25.50%)

Profitability

Metric LNAI PMCB Biotechnology median
Gross margin (3.48%) 95.64% 65.16%
Operating margin (9,184.79%) 0.00% 0.00%
Net margin (3,761.88%) 0.00% 0.00%
Free cash flow margin (5,610.24%) 0.00% 0.00%
Return on equity 23.46% (58.04%) (56.36%)
Return on assets (39.21%) (50.43%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LNAI PMCB Biotechnology median
Revenue growth (TTM) — (71.06%) 6.02%
EPS growth (last fiscal year) 98.77% (186.83%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric LNAI PMCB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.11 40.29 4.72
Net debt to EBITDA 0.20 5.41 0.96

Dividend

Metric LNAI PMCB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric LNAI PMCB Biotechnology median
Market cap 4.15m 3.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack